Does clobazam help agitation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Clobazam, a benzodiazepine medication, is likely to be effective in reducing agitation in various clinical settings, given the overall efficacy of benzodiazepines in managing agitation 1.

Key Points

  • Benzodiazepines, including clobazam, have been shown to be valuable in reducing agitation and are at least as effective as conventional antipsychotics like haloperidol 1.
  • While specific studies on clobazam are not mentioned in the provided evidence, the efficacy of benzodiazepines as a class in reducing agitation supports its potential use for this purpose 1.
  • The use of benzodiazepines, including clobazam, should be considered in the context of their potential benefits and risks, including the risk of dependence and withdrawal 1.
  • In clinical practice, benzodiazepines like clobazam may be used for short-term management of agitation, with careful consideration of the dose and duration of treatment to minimize adverse effects 1.
  • It is essential to weigh the benefits of using clobazam against its potential risks, especially in vulnerable populations such as older adults or those with a history of substance abuse 1.

Clinical Considerations

  • The dose of clobazam for agitation is not specified in the provided evidence, but typical doses of benzodiazepines for agitation range from 2 to 4 mg for lorazepam, which may guide the dosing of clobazam 1.
  • Treatment durations for agitation with benzodiazepines, including clobazam, can vary from several days to weeks, depending on the clinical context and patient response 1.

From the Research

Clobazam and Agitation

  • Clobazam is a 1,5-benzodiazepine with anxiolytic properties, which has been used to treat various types of anxiety disorders, including panic attacks and agitation associated with anxiety disorders 2, 3.
  • Studies have shown that clobazam can be effective in reducing anxiety and panic attacks in patients with anxiety disorders, with response rates ranging from 60% to 75% reduction in panic attacks 2.
  • Clobazam has also been shown to have a positive effect on state anxiety, with significant reductions in rating scores on anxiety scales such as the Hamilton Anxiety Scale (HAS) and Wittenborn Psychiatric Rating Scales (WPRS) 3.
  • Additionally, clobazam has been found to have a rapid onset of action, with significant improvements in anxiety symptoms observed early in treatment 3.

Mechanism of Action

  • Clobazam acts by allosterically activating the GABAA receptor, which is responsible for its anxiolytic and anticonvulsant effects 4, 5.
  • Clobazam has a high affinity for the GABAA receptor, which is thought to contribute to its efficacy in reducing anxiety and seizure activity 4.
  • The drug is also metabolized to an active metabolite, N-desmethylclobazam, which has a longer half-life than the parent compound and contributes to its therapeutic effects 5.

Clinical Use

  • Clobazam is approved for the treatment of seizures associated with Lennox-Gastaut syndrome, but it has also been used off-label for the treatment of anxiety disorders, including panic attacks and agitation 6, 4.
  • The dosage of clobazam used in clinical practice can vary depending on the indication and patient population, but typical doses range from 5-40 mg per day 4.
  • Clobazam is generally well-tolerated, with a safety profile similar to that of other benzodiazepines, but with less sedation and psychomotor impairment 6, 4.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.